[Immunocorrective properties of new antileprotic preparations].
Antimycobacterial and immunotropic characteristics of new antileprosy drugs, made in this country, have been studied and compared with those of dapsone. Animal experiments have demonstrated a high immunostimulating activity of the new drugs; this calls for clinical trials of these agents, for they may improve the therapy efficacy, help prevent the disease recurrences, and cut down the length of treatment for leprosy.
E N
EN
Goloshchapova
D000276:Adjuvants, Immunologic; D000818:Animals; D000921:Antibody-Producing Cells / Q000187:drug effects / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects; D007917:Leprostatic Agents / Q000627:therapeutic use* / Q000633:toxicity; D007918:Leprosy / Q000188:drug therapy / Q000276:immunology; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA
D000276:Adjuvants, Immunologic; D007917:Leprostatic Agents
Immunokorrigiruiushchie svoĭstva novykh protivoleproznykh preparatov.